PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
NASDAQ · Healthcare · Medical - Devices · US
$1.37
−0.72%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.51x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -12.82x
- Price / sales
- 2.67x
- Price / cash flow
- -2.62x
Enterprise value
- Enterprise value
- $895.1M
- EV / sales
- 5.62x
- EV / EBITDA
- -8.21x
- EV / EBIT
- -5.51x
- Market cap
- $425.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026